The loss of the Raf kinase inhibitor protein (RKIP), also known as a phosphatidylethanolamine binding protein 1 (PEBP1), is connected to the development of metastatic prostate cancers as well as a few other types of aggressive cancers [1]. This evidence concerns the gene PEBP1 and cancer.